Marshall Wace »

Werewolf Therapeutics shares owned by Marshall Wace

Quarter-by-quarter ownership of Werewolf Therapeutics (HOWL) shares owned by Marshall Wace from 13F filings

Historical chart of Marshall Wace investment in Werewolf Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Werewolf Therapeutics held by Marshall Wace consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Werewolf Therapeutics by Marshall Wace

Quarter filed Position value Share count Share price at filing
2024-03-31 $170k 26k 6.48
2023-03-31 $314k 121k 2.60

More positions owned by Marshall Wace

Ishares-s&p 500 Etp (IVV)
Amazon.com Common Stock (AMZN)
Microsoft Corp Common Stock (MSFT)
Alphabet Inc-a Common Stock (GOOGL)
Apple Common Stock (AAPL)
Nvidia Corp Common Stock (NVDA)
Vanguard S&p 500 Etp (VOO)
Alphabet Inc-c Common Stock (GOOG)
Spdr S&p 500 Etf Equity Option Put Option (SPY)
Danaher Corp Common Stock (DHR)
Meta Platforms-a Common Stock (META)
Netflix Common Stock (NFLX)
Costco Wholesale Common Stock (COST)
Procter & Gamble Common Stock (PG)
Adv Micro Device Common Stock (AMD)

View all positions for Marshall Wace

Top funds holding Werewolf Therapeutics

RA Capital Management
MPM Asset Management
Partner Fund Management
Adage Capital Partners GP
MPM Oncology Impact Management
Bank of America Corporation
Henderson Group
Rubric Capital Management
Vanguard Group
Monashee Investment Management
Eagle Health Investments
Sphera Funds Management
DC Funds
Verition Fund Management
Millennium Management

View all funds holding Werewolf Therapeutics